GYRE short interest
Gyre Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 1,918,512 |
|---|---|
| Change vs prior report | 188,297 (+10.9%) |
| Change over six months | +25.7% |
| Days to cover | 6.92 (sector: 3.78) |
| Average daily volume | 277,117 |
| Rank in Healthcare | #258 of 922 by days to cover |
GYRE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 1,918,512 | +10.9% | 6.92 | 277,117 |
| 2026-09-15 | 1,730,215 | +1.2% | 19.22 | 90,007 |
| 2026-08-31 | 1,709,352 | -2.1% | 34.43 | 49,644 |
| 2026-08-14 | 1,745,865 | -4.3% | 31.05 | 56,232 |
| 2026-07-31 | 1,823,720 | -10.7% | 37.39 | 48,780 |
| 2026-07-15 | 2,043,169 | +11.8% | 24.18 | 84,482 |
| 2026-06-30 | 1,826,634 | +5.0% | 11.78 | 155,116 |
| 2026-06-15 | 1,740,077 | +4.0% | 18.43 | 94,410 |
| 2026-05-29 | 1,672,318 | -0.2% | 17.64 | 94,813 |
| 2026-05-15 | 1,675,711 | +6.0% | 18.17 | 92,210 |
| 2026-04-30 | 1,580,423 | -0.2% | 32.58 | 48,509 |
| 2026-04-15 | 1,584,269 | +3.8% | 25.93 | 61,093 |
| 2026-03-31 | 1,525,798 | +10.8% | 10.82 | 141,008 |
| 2026-03-13 | 1,377,210 | +2.5% | 8.36 | 164,693 |
| 2026-02-27 | 1,344,228 | -9.3% | 18.56 | 72,409 |
| 2026-02-13 | 1,482,748 | +4.4% | 27.89 | 53,165 |
| 2026-01-30 | 1,420,459 | -4.9% | 18.46 | 76,947 |
| 2026-01-15 | 1,494,183 | +8.5% | 17.65 | 84,646 |
| 2025-12-31 | 1,377,062 | -0.5% | 13.05 | 105,511 |
| 2025-12-15 | 1,384,238 | -5.9% | 19.52 | 70,908 |
| 2025-11-28 | 1,470,729 | -0.4% | 27.75 | 53,006 |
| 2025-11-14 | 1,476,320 | -4.1% | 26.45 | 55,815 |
| 2025-10-31 | 1,540,111 | +2.5% | 22.96 | 67,091 |
| 2025-10-15 | 1,502,320 | -10.1% | 14.93 | 100,600 |
| 2025-09-30 | 1,670,982 | +3.2% | 16.17 | 103,331 |
import finzdata as yf
yf.Ticker("GYRE").short_interest # every report since 2017
yf.Client().short_interest(["GYRE"], start="2018-01-01")Healthcare short interest · GYRE price history · Who owns GYRE · All short interest